Lexicon Pharmaceuticals
LXRX
LXRX
136 hedge funds and large institutions have $1.64B invested in Lexicon Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 48 increasing their positions, 43 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
9% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 23
6% less funds holding
Funds holding: 145 → 136 (-9)
Holders
136
Holding in Top 10
2
Calls
$5.09M
Puts
$4.61M
Top Buyers
| 1 | +$69.4M | |
| 2 | +$10.3M | |
| 3 | +$8.39M | |
| 4 |
HCM
Highbridge Capital Management
New York
|
+$7.81M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$7.38M |
Top Sellers
| 1 | -$3.71M | |
| 2 | -$1.75M | |
| 3 | -$1.67M | |
| 4 |
Citigroup
New York
|
-$1.56M |
| 5 |
AP
AHL Partners
London,
United Kingdom
|
-$1.18M |